Prescription drug · NDA
Rhopressa (Netarsudil) NDC 70727-497
Netarsudil mesylate .2 mg/mL · Solution/ drops · Ophthalmic, Topical · Alcon Laboratories, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70727-497-25 | 70727049725 | 1 BOTTLE in 1 CARTON (70727-497-25) / 2.5 mL in 1 BOTTLEMarketed from Dec 18, 2017 | |
| 70727-497-99 | 70727049799 | 1 BOTTLE in 1 CARTON (70727-497-99) / 2.5 mL in 1 BOTTLEMarketed from Dec 18, 2017 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rhopressa
- Generic name (nonproprietary)
- netarsudil
- Active ingredients
- Netarsudil mesylate — .2 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic, Topical
- Labeler
- Alcon Laboratories, Inc.NDC labeler code 70727
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208254
- Marketing start
- Listing expires
- Other FDA classes
- Rho Kinase Inhibitors (Mechanism)
- Identifiers
- Product ID 70727-497_82acde68-4935-4dc9-82ff-9ff7f449f893SPL ID 82acde68-4935-4dc9-82ff-9ff7f449f893SPL set ID 7d4f0e3a-5b86-4c43-982a-813b22ae7e22RxCUI 1992868, 1992873UNII VL756B1K0UUPC 0370727497255
- Pharmacologic class
- Rho Kinase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic, Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470727049725followed by a unit qualifier and the quantityPackage 70727-0497-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. RHOPRESSA ® is a Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70727-497
- What is NDC 70727-497?
- 70727-497 is the product NDC for Rhopressa (netarsudil), Netarsudil mesylate .2 mg/mL solution/ drops, listed with the FDA by Alcon Laboratories, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Rhopressa (Netarsudil).
- What is the active ingredient?
- Netarsudil mesylate.
- Who is the labeler?
- Alcon Laboratories, Inc., NDC labeler code 70727. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Rhopressa?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.